Implications of the Facing Dementia Survey for policy makers and third-party organisations across Europe

International Journal of Clinical Practice, Supplement

Volumn 59, Issue 146, 2005, Pages 34-38

  Rimmer, Elizabeth ^a   Stave, C ^b   Sganga, A ^b   O'Connell, B ^c  

^a Alzheimer's Disease International   (United Kingdom)

^b PFIZER INC   (United States)

^c Millward Brown North America   (United States)

Author keywords

Alzheimer's disease; Dementia; Early diagnosis; Societal impact

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; DEMENTIA; FINANCIAL MANAGEMENT; FRANCE; GERMANY; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; ITALY; LONG TERM CARE; MEDICAL SOCIETY; POLAND; POPULATION RISK; PREVALENCE; PRIORITY JOURNAL; PUBLIC OPINION; QUALITATIVE ANALYSIS; SPAIN; UNITED KINGDOM; AGED; AWARENESS; EARLY DIAGNOSIS; EUROPE; HEALTH CARE PLANNING; HEALTH EDUCATION;

AGED; ALZHEIMER DISEASE; AWARENESS; EARLY DIAGNOSIS; EUROPE; HEALTH EDUCATION; HEALTH POLICY; HEALTH PRIORITIES; HUMANS;

EID: 14744285215     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1368-504x.2005.00486.x     Document Type: Article

References (1)

1. O'Brien JT. Drugs for AD: cholinesterase inhibitors have passed NICE's hurdle. BMJ 2001; 323: 123-4.